Ice-temperature organ protection solution

A technology for protecting liquids and organs, which is applied in the field of protective liquids for organ preservation, which can solve problems such as damage to cell osmotic pressure balance, high liquid viscosity, and complex components, and achieve improved perfusion effects, low viscosity, and simple formula Effect

Inactive Publication Date: 2013-10-23
TIANJIN UNIV OF COMMERCE
View PDF2 Cites 2 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

Although UW fluid basically meets the above conditions, in addition to complex components and high price, it also has high fluid viscosity, slow cooling of organs, poor buffering capacity, K + Defects such as high content
For this reason, a series of organ protection solutions have also been developed in China, but the storage adaptation temperature of the above-mentioned protection solutions is in the range of 0-4°C, and the upper limit is taken

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Examples

Experimental program
Comparison scheme
Effect test

preparation example Construction

[0015] The preparation method of the present invention is that the above-mentioned components are added into the water for injection and completely dissolved, and the astragalus extract is directly added. After preparation, the liquid was sterilized under high temperature and high pressure at 109°C for 45 minutes. The pH value of the prepared liquid was 7.20±0.04, and the osmotic pressure was 340mOsm / L.

[0016] The following examples take animal pig kidney as the object of preservation. The perfusion method is: use 1°C organ protection solution to perfuse under gravity pressure, the perfusion flow rate is 2.7ml / s, and stop when the temperature of the protection solution flowing out of the kidney vein is 3.0°C; after the perfusion, the kidney is placed in a Store in an incubator at 0±0.15°C. Table 1 shows the biochemical indicators of kidneys with different formulations of ice-temperature organ protection solution and different storage times. RCR in the table represents the ...

Embodiment 1

[0017] Embodiment 1: Containing potassium citrate is 0.9g in every 100ml ice temperature organ protection liquid; Sodium citrate is 1.0g; Magnesium sulfate is 1.05g; Mannitol is 5.58g; g; Astragalus extract 5ml, after mixing the above ingredients, add water for injection in a 100ml volumetric flask to dilute to 100ml.

Embodiment 2

[0018] Embodiment 2: Containing potassium citrate is 1.0g in every 100ml ice temperature organ protection solution; Sodium citrate is 1.05g; Magnesium sulfate is 1.1g; Mannitol is 6.3g; g; Astragalus extract 5ml, after mixing the above ingredients, add water for injection in a 100ml volumetric flask to dilute to 100ml.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The invention discloses an ice-temperature organ protection solution. A sterilizing aqueous solution is prepared from potassium citrate, sodium citrate, magnesium sulfate, mannitol, 6-aminoadenine phosphate, astragalus membranaceus and water for injection by mixing. Every 100ml of the ice-temperature organ protection solution comprises 0.87-1.16g of potassium citrate, 0.98-1.19g of sodium citrate, 1.02-1.15g of magnesium sulfate, 5.56-6.85g of mannitol and 0.45g of 6-aminoadenine phosphate and 5ml of astragalus membranaceus extract. The ice-temperature organ protection solution is prepared by mixing the potassium citrate, the sodium citrate, the magnesium sulfate, the mannitol, the 6-aminoadenine phosphate and the astragalus membranaceus, and adding the water for injection into a 100ml bottle to dilute the volume to 100ml. Because the proportion of the mannitol is increased, the phase-transition temperature point of the ice-temperature organ protection solution can be decreased, and the ice-temperature organ protection solution is more suitable for preserving an organ at ice temperature. The added astragalus membranaceus has the functions of resisting the oxidative damage and promoting the activity of a Na<+>-K<+>-ATP enzyme. The ice-temperature organ protection solution has low viscosity and a good perfusion effect and can decrease the temperature of an organ rapidly in a short time.

Description

technical field [0001] The invention belongs to a protective liquid for organ preservation, in particular to an organ protective liquid suitable for freezing temperatures. Background technique [0002] Organ preservation is one of the three technical pillars of organ transplantation. Due to the emergence of organ protection solutions, organ preservation technology has made great progress in the past 10 years. An ideal preservation solution can provide a suitable microenvironment for isolated organs and maximize the preservation time of organs. It has always been a research hotspot in the field of organ transplantation. The most commonly used clinically is the UW solution (University of Wisconsin Solution) developed by the University of Wisconsin. Due to its good clinical and experimental preservation effects, this preservation solution is considered as a standard organ preservation solution, but its price is relatively expensive, which limits its wide application in the fie...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
IPC IPC(8): A01N1/02
Inventor 诸凯王雅博梁飞张雅敏史源
Owner TIANJIN UNIV OF COMMERCE
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products